Cargando…

Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots

All worldwide newborn screening (NBS) for lysosomal storage diseases (LSDs) is performed as a first-tier test by measurement of lysosomal enzymatic activities in dried blood spots (DBS). The currently two available methodologies used for measurement of enzymatic activities are tandem mass spectromet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gelb, Michael H., Lukacs, Zoltan, Ranieri, Enzo, Schielen, Peter C. J. I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448570/ https://www.ncbi.nlm.nih.gov/pubmed/30957052 http://dx.doi.org/10.3390/ijns5010001

Ejemplares similares

Newborn Screening for Lysosomal Storage Diseases: A Concise Review of the Literature on Screening Methods, Therapeutic Possibilities and Regional Programs
por: Schielen, Peter C. J. I., et al.
Publicado: (2017)

Dried Blood Spot (DBS) Methodology Study for Biomarker Discovery in Lysosomal Storage Disease (LSD)
por: Rus, Corina-Marcela, et al.
Publicado: (2021)

Newborn Screening for Lysosomal Storage Diseases: Methodologies, Screen Positive Rates, Normalization of Datasets, Second-Tier Tests, and Post-Analysis Tools
por: Gelb, Michael H.
Publicado: (2018)

At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn Screening
por: Lukacs, Zoltan, et al.
Publicado: (2020)

The Importance of Assay Imprecision near the Screen Cutoff for Newborn Screening of Lysosomal Storage Diseases
por: Robinson, Bruce H., et al.
Publicado: (2019)

New Perspectives in Dried Blood Spot Biomarkers for Lysosomal Storage Diseases
por: Spiewak, Justyna, et al.
Publicado: (2023)

Stratification of patients with lysosomal acid lipase deficiency by enzyme activity in dried blood spots
por: Hong, Xinying, et al.
Publicado: (2022)

Toward Newborn Screening of Cerebrotendinous Xanthomatosis: Results of a Biomarker Research Study Using 32,000 Newborn Dried Blood Spots
por: Hong, Xinying, et al.
Publicado: (2020)

Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia
por: Grecsó, Nóra, et al.
Publicado: (2020)

Current State of the Art of Newborn Screening for Lysosomal Storage Disorders
por: Millington, David S., et al.
Publicado: (2018)

Influence of Hematocrit and Total-Spot Volume on Performance Characteristics of Dried Blood Spots for Newborn Screening
por: Hall, Elizabeth M., et al.
Publicado: (2015)

Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry()
por: Elliott, Susan, et al.
Publicado: (2016)

Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns
por: Chien, Yin-Hsiu, et al.
Publicado: (2020)

Fragile X protein in newborn dried blood spots
por: Adayev, Tatyana, et al.
Publicado: (2014)

Dataset and standard operating procedure for newborn screening of six lysosomal storage diseases: By tandem mass spectrometry
por: Elliott, Susan, et al.
Publicado: (2016)

Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy
por: Wu, Chen, et al.
Publicado: (2017)

Improved Dried Blood Spot PCR Assay for Universal Congenital Cytomegalovirus Screening in Newborns
por: Kim, Jean H., et al.
Publicado: (2023)

Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
por: Herbst, Zackary M., et al.
Publicado: (2020)

Effects of Dried Blood Spot Storage on Lipidomic Analysis
por: Di Marino, Cinzia, et al.
Publicado: (2018)

Newborn Dried Blood Spots for Serologic Surveys of COVID-19
por: Liu, Feimei, et al.
Publicado: (2020)

The view of Hong Kong parents on secondary use of dried blood spots in newborn screening program
por: Hui, L. L., et al.
Publicado: (2022)

Creatine kinase‐MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy
por: Park, Sunju, et al.
Publicado: (2022)

A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage Disorders †
por: Sanders, Karen A., et al.
Publicado: (2020)

Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study
por: Chuang, Chih-Kuang, et al.
Publicado: (2017)

Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm
por: la Marca, Giancarlo, et al.
Publicado: (2023)

Effects of drying and storage conditions on the stability of TSH in blood spots
por: Magalhães, Patrícia Künzle Ribeiro, et al.
Publicado: (2018)

Establishment of Cutoff Values for Newborn Screening of Six Lysosomal Storage Disorders by Tandem Mass Spectrometry
por: Li, Ruotong, et al.
Publicado: (2022)

Investigation of newborns with abnormal results in a newborn screening program for four lysosomal storage diseases in Brazil
por: Bravo, Heydy, et al.
Publicado: (2017)

Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II
por: Herbst, Zackary M., et al.
Publicado: (2022)

Exploring existing and deliberated community perspectives of newborn screening: informing the development of state and national policy standards in newborn screening and the use of dried blood spots
por: Muchamore, Ian, et al.
Publicado: (2006)

Tandem Mass Spectrometry Assays of Palmitoyl Protein Thioesterase 1 and Tripeptidyl Peptidase Activity in Dried Blood Spots for the Detection of Neuronal Ceroid Lipofuscinoses in Newborns
por: Barcenas, Mariana, et al.
Publicado: (2014)

Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia
por: Grecsó, Nóra, et al.
Publicado: (2021)

Direct Derivatization in Dried Blood Spots for Oxidized and Reduced Glutathione Quantification in Newborns
por: Ten-Doménech, Isabel, et al.
Publicado: (2022)

Trace elements in dried blood spots as potential discriminating features for metabolic disorder diagnosis in newborns
por: Moreda-Piñeiro, Jorge, et al.
Publicado: (2021)

Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population
por: Han, Minje, et al.
Publicado: (2011)

Rapid and Modular Assembly of Click Substrates To Assay Enzyme Activity in the Newborn Screening of Lysosomal Storage Disorders
por: Skrinjar, Philipp, et al.
Publicado: (2018)

2335. Newborn Dried Blood Spot for Retrospective Diagnosis of Congenital Cytomegalovirus (CMV) Infection: It’s Time for Universal Screening!
por: Medoro, Alexandra K, et al.
Publicado: (2019)

Effects of Long-Term Storage on the Biobanked Neonatal Dried Blood Spot Metabolome
por: Ottosson, Filip, et al.
Publicado: (2023)

Reference values for lysosomal enzymes activities using dried blood spots samples - a Brazilian experience
por: Müller, Karen B, et al.
Publicado: (2010)

LC-MS/MS-based enzyme assay for lysosomal acid lipase using dried blood spots
por: Ohira, Mari, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_85mpi02c8skblb82a5fnup30ep